Evidence map›Paper›PMID 18275915›Full record

ReviewDrug discovery today2008

The application of FAST-NMR for the identification of novel drug discovery targets.

Robert Powers, Kelly A Mercier, Jennifer C Copeland

Abstract readReview
In one paragraph

Review in Drug discovery today, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. NMR Metabolomics Protocols for Drug Discovery.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. PROFESS: a PROtein function, evolution, structure and sequence database.Database : the journal of biological databases and curation · 2010
    Article
  14. Article
  15. Advances in Nuclear Magnetic Resonance for Drug Discovery.Expert opinion on drug discovery · 2009
    Article
  16. Structure and function of Pseudomonas aeruginosa protein PA1324 (21-170).Protein science : a publication of the Protein Society · 2009
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Robert PowersDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE 68522, USA. rpowers3@unl.edu
Kelly A Mercier
Jennifer C Copeland

Funding

Sub-project 9U54GM074958 · NIGMS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI KENNEDY, MICHAEL ALLEN · 2005 to 2009
$56.6M
NIGMS NIH HHS U54 GM074958
6 · The paper itself

Abstract

The continued success of genome sequencing projects has resulted in a wealth of information, but 40-50% of identified genes correspond to hypothetical proteins or proteins of unknown function. The functional annotation screening technology by NMR (FAST-NMR) screen was developed to assign a biological function for these unannotated proteins with a structure solved by the protein structure initiative. FAST-NMR is based on the premise that a biological function can be described by a similarity in binding sites and ligand interactions with proteins of known function. The resulting co-structure and functional assignment may provide a starting point for a drug discovery effort.

Indexed as

Drug DesignAlgorithmsComputational BiologyDrug Delivery SystemsHumansModels, MolecularMolecular StructureNuclear Magnetic Resonance, Biomolecular

Identifiers

PMID18275915
PMCPMC2754198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.